Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:29 AM
Ignite Modification Date:
2025-12-25 @ 12:29 AM
NCT ID:
NCT02910167
Eligibility Criteria:
Inclusion criteria:
1. Patients 18 years of age and older who have received at least one dose of BUSCAPINA COMPOSITUM N according to label indications and who attend to one of the pharmacies, clinics, or private doctors office selected for the study.
2. Patients who agree to adhere to the protocol procedures of this study.
3. Women who are not pregnant or breast feeding
4. Persons who sign the informed consent
Exclusion criteria:
1. Patients with allergy to BUSCAPINA COMPOSITUM N or any of the compounds in the formula.
2. Patients with mechanical stenosis of the gastrointestinal tract.
3. Patients with myasthenia gravis.
4. Patients with megacolon.
5. Patients breastfeeding at the time of enrollment or who have become pregnant during treatment with BUSCAPINA COMPOSITUM N.
6. Patients with clinical evidence of immunosuppression.
7. Patients with urinary retention subvesical obstruction (such as prostatic adenoma).
8. Patients with right-angle glaucoma.
9. Patients with tachycardia and tachyarrhythmia.
10. Patients with severe hepatic impairment.
11. Patients with psychiatric disorders.
12. Patients with alcohol dependence or drugs.
13. Patients who discontinue the protocol are not eligible for re-enrollment.
14. Researchers, company personnel or their relatives.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02910167
Study Brief:
Protocol Section:
NCT02910167